OcuSciences Welcomes Michael Patane, PhD, to its Board of Directors
ANN ARBOR, Mich.--(BUSINESS WIRE)--OcuSciences, a medical device company developing ocular imagers to detect early disease by assessing retinal metabolic activity, today announced the addition of Michael Patane, PhD, to its Board of Directors. Dr. Patane brings over 25 years of drug discovery and development experience, with a proven track record of leadership in startup, biotechnology and pharmaceutical companies. Many of these roles included ophthalmic product creation and development. Most r